FDA approves new Alzheimer's drug

The FDA approved an Alzheimer's drug, which slows down the disease, according to phase 3 trial results. Leqembi is the first drug that's been shown to help slow memory decline in patients. But the drug does come with some potential safety risks. Katie McDonough, the community executive director of the Alzheimer's Association Southeastern Virginia Chapter joins FOX 5 to discuss the new drug.